EUVIMEDEUVIMED entdecken
Crossref

Glymphatic System Reconstruction in the Management of Alzheimer’s Disease

Ashkan Asgari Gashtrodkhani, Roxana Kaveh, Zoheir Reihanian, Shahrokh Yousefzadeh-Chabok, Sasan Andalib

Iranian Journal of Neurosurgery · 2025-01 · 11 (Continuous Publishing)

DOI: 10.32598/irjns.11.26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Neurosurgery, 2025-01. Verfasst von Ashkan Asgari Gashtrodkhani und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a major public health challenge.The exact cause of AD is unknown, but it is characterized by progressive impairment in cognitive and memory functions and pathological changes in the brain, such as aggregation of two main proteins, amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) of tau.Nonetheless, the pathogenesis of AD appears to be complicated by vascular changes, neuroinflammation, synaptic loss, and impaired clearance of cellular waste products.Currently, the limited efficacy of available treatments underscores the need for alternative therapeutic strategies.The glymphatic system is a paravascular network in the central nervous system, responsible for the removal of cellular waste.The present review discusses the glymphatic system and its reconstructive surgery as a potential treatment approach for AD.Both experimental and human studies have demonstrated the role of the impaired glymphatic system in the pathogenesis of AD by increasing the accumulation of Aβ and tau proteins, thus holding potential as a new target for AD treatment.Moreover, glymphatic system dysfunction can lead to neurodegeneration, cognitive decline, and disease progression.Studies have also shown the potential role of microsurgical lymphatic reconstruction as a possible therapeutic target for AD treatment.Glymphatic system dysfunction may be a possible contributing factor to the pathogenesis and progression of AD.Moreover, glymphatic and meningeal reconstruction microsurgery may have the potential for the treatment of AD.

Zitieren

APA

Gashtrodkhani, A. A., Kaveh, R., Reihanian, Z., Yousefzadeh-Chabok, S., & Andalib, S. (2025). Glymphatic System Reconstruction in the Management of Alzheimer’s Disease. Iranian Journal of Neurosurgery, 11(Continuous Publishing). https://doi.org/10.32598/irjns.11.26

Vancouver

Gashtrodkhani AA, Kaveh R, Reihanian Z, Yousefzadeh-Chabok S, Andalib S. Glymphatic System Reconstruction in the Management of Alzheimer’s Disease. Iranian Journal of Neurosurgery. 2025;11(Continuous Publishing). doi:10.32598/irjns.11.26

BibTeX
@article{Gashtrodkhani2025,
  author = {Gashtrodkhani, Ashkan Asgari and Kaveh, Roxana and Reihanian, Zoheir and Yousefzadeh-Chabok, Shahrokh and Andalib, Sasan},
  title = {Glymphatic System Reconstruction in the Management of Alzheimer’s Disease},
  journal = {Iranian Journal of Neurosurgery},
  year = {2025},
  volume = {11},
  number = {Continuous Publishing},
  doi = {10.32598/irjns.11.26}
}
Kostenlos starten →